← all works
RoB 2: a revised tool for assessing risk of bias in randomised trials
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Abstract
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- BMJ
- Topic
- Meta-analysis and systematic reviews
- Field
- Decision Sciences
- Canadian institutions
- McGill UniversityJewish General HospitalSt. Michael's HospitalUniversity of Alberta
- Funders
- National Eye InstituteMedical Research CouncilNational Institutes of HealthBiosensors International GroupCanada Research ChairsUniversity of BristolDepartment of Health and Social CareMedicines CompanyNational Institute for Health and Care ResearchEli Lilly and CompanyUniversity Hospitals Bristol NHS Foundation TrustNIHR Bristol Biomedical Research CentreNational Health and Medical Research CouncilAcademy of Medical SciencesCancer Research UKPatient-Centered Outcomes Research InstituteCHDI FoundationWellcome TrustAmgen
- Keywords
- Systematic reviewMedicineRandomized controlled trialPublication biasClinical trialMEDLINEComputer scienceMeta-analysisMedical physicsInternal medicine
- Has abstract in OpenAlex
- yes